secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001213900-25-072781
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical acquires SiVantage and SIMPL Medical assets, hires former SiVantage founders as executives
--------------------------------------------------------------------------------

- Acquired substantially all assets of SiVantage (SImmetry) and SIMPL Medical on Aug 1, 2025, for cash, stock, and royalties.
- SImmetry consideration includes $750K cash, 710,300 shares (473,533 pledged for 1 year), royalty 15%/10% over 5 years (cap $5M), up to $1.3M deferred cash, and earnout shares.
- SIMPL consideration: 30% royalty on net revenue for 5 years (20% after aggregate exceeds $20M); optional stock payment up to 33.3% of quarterly royalty.
- Wyatt Geist named Chief Innovation Officer, Nate Grawey named Chief Commercial Officer; each gets $290K base salary and 138,114 restricted shares.
- Portfolio now includes SImmetry, SImmetry+, and SIMPL products, making Tenon a multi-approach sacro-pelvic fusion company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390025072781/0001213900-25-072781-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390025072781/ea0252007-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-072781

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer